The relative glycemic impact (RGI), the weight of glucose that would induce a glycemic response equivalent to that induced by a given amount of food, is preferably expressed for reference amounts of foods customarily consumed per eating occasion. But because customarily consumed portions of different foods deliver different glycemic carbohydrate doses, methods for determining their RGI need to allow for homeostatic responses to different glycemic carbohydrate loadings. We tested the accuracy of an in vitro method for measuring the RGI of customarily consumed portions that allows for homeostasis, using 24 foods. Glucose equivalents released during simulated gastrointestinal digestion were adjusted by the glycemic potency of contributing sugars to obtain cumulative glycemic glucose equivalents (GGE) and multiplied by food portion weight. Corresponding dose-dependent blood glucose clearance was calculated and subtracted from GGE, giving net GGE compared with time curves reminiscent of blood glucose response curves. RGI values (GGE content) for the food portions were obtained by comparing incremental areas under the curves for foods with that for a
Introduction
With the increasing incidence of metabolic syndrome and ageing populations, glucose intolerance will continue to be a global problem (1) . Because high blood glucose concentrations (2) and blood glucose excursions (3) are risk factors for a number of diseases, blood glucose response to foods remains a very relevant biomarker on which to base values to guide selection of foods as part of managing long-term health outcomes.
A lack of values to guide food choices based on the food effects has been a long-standing problem (4) . The American Association of Cereal Chemists recognized the need to "communicate glycemic response in grams per serving of food" (5) and established an ad hoc committee to consider how to express glycemic impact of foods for consumer use. This committee decided that (relative) glycemic impact (RGI) 4 should be expressed as glucose equivalents and defined as "the weight of glucose that would induce a glycemic response equivalent to that induced by a given amount of food." It also recommended that such values be measured using "validated in vitro methodology that accurately mimics in vivo behavior" (6) . At the same time, the U.S. FDA has stipulated that food values, such as nutrient data, should be presented in terms of "reference amounts customarily consumed per eating occasion" (7) for comparability and relevance.
Basing food selection on relative glycemic effects expressed as grams of glucose equivalents (GGE), and on servings or amounts of entire foods customarily consumed per eating occasion has a number of practical advantages over data such as the glycemic index (GI) (8) . Although GI is determined from the responses to a food, it is calculated and expressed as if an individual food component, available carbohydrate, were responsible for the food effect, and does not change as a function of food intake. But whether expressed on a whole-food or on a carbohydrate-only basis, there remains the persistent problem of low precision in clinical measures of glycemic response due to both intra-and inter-individual variation (9, 10) . Low precision makes the task of establishing differences between foods logistically demanding and expensive because of the numbers of participants required to adequately power tests of difference between foods. It also leaves a great deal of uncertainty about the extent to which the values show true differences between foods.
One way of overcoming clinical variation in RGI is to base the measurement of RGI on in vitro digestion and to conceptualize glycemic impact in the physical sense of a rapidly imposed stress imposed by a food, an impact distinct from the strain or effect that is the postprandial glycemic response to the glycemic impact. The impact thus precedes the intervening physiological variables that lead to individual differences and fluctuations in response and is free of their influence. RGI can then be regarded as a food property and measured in much the same way as available carbohydrate, with enough precision to allow it to be used as a continuous variable with which to discriminate between foods. The analysis must, however, satisfy a number of conditions for it to be a measure of glycemic impact. These conditions are: 1) the food should be in the physical form in which it is swallowed; 2) the parameters of digestion should parallel the conditions to which the food is exposed in the gut as far as is practical; 3) the results should be able to be related to customarily consumed portion sizes; 4) the different relative glycemic potencies of the released sugars should be allowed for; and 5) the rate of blood glucose clearance and its dose dependence should be accounted for (11, 12) .
In addition, the procedure should be economical, practical, accurate, and precise, so it can be used to rapidly populate a food composition database with useable values for the GGE content, i.e. the RGI of foods (8) .
In this article, we present the results of analyzing a set of foods, for which glycemic responses had been clinically measured, by a new in vitro procedure that takes into account dosedependent rates of blood glucose clearance (12) . The method allows all of the analytical conditions listed above to be satisfied and meets the criteria of economy, practicality, accuracy, validity, and precision. As well as further validating the procedure, this report provides an opportunity to suggest how the data may be presented as a guide to food choices for glycemic control.
Methods
Foods. A range of British foods for which GI values were available (13, 14) was purchased from a Tesco supermarket in Oxford, UK. The foods included bakery products, breakfast cereals, pasta, pulses, and starchy vegetables (potato Marfona).
Sample preparation. The products were prepared as directed on the packaging where appropriate and rubbed through a 5-mm stainless steel sieve (Retsch). Subsamples of the sieved materials were moistened and tested for mouthfeel and any that felt as if they would require further chewing were rubbed through a 2-mm sieve and again tested for mouthfeel. The only materials requiring further particle size reduction after the 5.0-mm sieving were pulses, which had retained a granular texture after the 5-mm sieving.
Digestion procedure. The digestion procedure was typical of many that use a simulated gastric digestion followed by a pancreatic digestion (15) and has recently been described in detail (12) . Release of sugars and dextrins during in vitro digestion was determined as glucose equivalents per gram by measuring reducing sugar after the secondary amyloglucosidase/invertase digestion of aliquots of digesta taken at 20, 40, 60, and 180 min of digestion.
Data analysis. The RGI, as GGE per serving of food, was determined from the initial measurements of in vitro digestion by the following steps, which were achieved quickly by pasting the values for GGE release per gram and serving size into an Excel spreadsheet containing the required formulae ( Table 1) . The sugar values were converted to GGE/g ( Fig. 1 ; Table 1 , row 2) by allowing for the glycemic potency of fructose present (fructose GI = 22%). In the foods analyzed here, no allowance was made for lactose. The values for GGE/g were multiplied by the portion size of the food (Table 1 , row 4), giving curves of GGE release per serving as a function of time of digestion. Cumulative apparent glucose clearance in response to the GGE content of a serving was determined (Table 1, row 7) using the formula for GGE clearance rate as a function of GGE intake [GD rate = 0.0135GGE + 0.0232 (GGE/min)], which had been determined in a previous study (12) . The 40-min GGE value was used as a measure of the acutely released carbohydrate. Cumulative apparent glucose clearance was subtracted from cumulative GGE release (Fig. 2) to provide a value for netGGE at each time point (Table 1 , row 8). Finally, the net GGE values were plotted against time to provide graphs for each food of the extent to which GGE loading exceeded GGE clearance with time ( Fig. 3) , and the area under this curve was calculated using the trapezoid summation technique (16) . The GGE content of the foods was then determined using a white bread reference for which the area under the curve had been measured. GGE content for the white bread reference was estimated from its carbohydrate content and a GI of 70, which is the mean value obtained from numerous measurements (17) ( Table 2) .
Validation. The validity of the procedure was tested by comparing the in vitro values obtained here with estimates of GGE based on published GI 1 Sugar release per gram of food in vitro adjusted by GI of sugars. 2 Ten minutes was added to the in vitro time to allow for the delay in onset of glycemic response. 3 GGE per gram of food determined in vitro, multiplied by portion size. 4 Rate of apparent glucose disposal (GD) as a function of GGE intake: GD rate = 0.0135GGE + 0.0232 (x = GGE release after 40 min in vitro digestion, y = GGE disposal/min) (12). 5 Cumulative glucose clearance (GGE clearance rate 3 time; row 2 3 row 6 column A). 6 GGE per portion minus GGE disposal (row 5 2 row 7). 7 Calculated by extending the line through the last 2 positive values to the x axis. 8 Time with baseline value (y = 0) added. 9 Net GGE (row 8) with final baseline value (0) added. 10 Area under adjacent points in curve of netGGE vs. time. 11 Area under the curve of net GGE versus time calculated by trapezoid summation.
values for the same foods (13, 14) . Clinical GGE values for servings of the foods were estimated as adjusted glycemic load (AGL) values by adjusting glycemic load (GL; the product of GI and the carbohydrate content) by a factor to account for the error in GL due to the difference in glucose clearance rate for a 50-g glucose intake, used as the reference in GI determination, and at the GGE dose contributed by the consumed serving of food (18) . The correspondence between the in vitro GGE values and estimates based on clinical data were tested in an analysis of correlation (Fig. 4) and in a Bland Altman methods comparison (19) , in which the difference between the in vitro and in vivo measurements was plotted against the mean of the two (Fig. 5) .
The precision of the measurements of sugar release was determined using a standard Microsoft Excel statistical package. SD of the corrected GL values (AGL) were estimated from the SEM of GI values. SD values for GGE were determined from the SD of the values for in vitro sugar release on which the GGE values were based (Table 1) .
Results
The results from the different steps in determining the GGE values per serving of the various foods are shown in Figs. 1-3. On a per-100-g food basis, the foods differed widely in rate and amount of GGE release and, therefore, in the shapes of their digestion curves (Fig. 1) . In foods with a high water content, such as pasta and cooked pulses, the digestion curves were low. In most bakery and breakfast cereal products, most of the digestion occurred rapidly and was substantially complete after 20-40 min of pancreatin digestion, giving an angular digestion profile. In contrast, other foods, such as pulses and pasta, showed a much lower and more prolonged digestion. At 180 min from adding pancreatin, most of the potentially available carbohydrate, defined as that which had been digested at 240 min in samples homogenized at 180 min, had been digested from most foods.
When differences in serving size and rates of theoretical glucose clearance (Fig. 2) were taken into account in the calculation of RGI (Table 1) , the curves of net GGE were markedly different for the various foods (Fig. 3) and gave a wide range of IAUC values (Table 2) .
A comparison of the GGE values obtained in this study with the GGE estimates (as AGL), based on published GI and GL values, showed that the in vitro results obtained here were reasonable predictors of clinical values (Fig. 4) . The equation of the line of relationship between the in vitro and in vivo AGL results was:
In vivoGGE ¼ 1:0 In vitroGGE20:50; R 2 ¼ 0:90:
The Bland Altman methods comparison (Fig. 5) showed a close agreement between the in vitro and in vivo methods:
In vivoGGE¼ 20:055In vitroGGE þ 1:16; R 2 ¼ 0:027:
The CV for the in vitro method for RGI determination was 6.1% compared with a value of 44.1% for the GI values from which the in vivo (AGL) values were calculated (13, 14) . Table 2 and GGE disposal (Fig. 2) .
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Discussion
The purpose of the in vitro method described here was to provide values for the glycemic impact of customarily consumed portions of whole foods. It achieved its aim by allowing for the differing glycemic potencies of the released sugars, expressing the results in terms of the glycemic potency of the entire foods, rather than of carbohydrate alone, and by allowing for the homeostatic adjustment of the body to blood glucose loading as a function of food intake (Fig. 2) so the results could be applied accurately to a customary intake of food. It is also noteworthy that the procedure produced curves reminiscent of blood glucose response curves (Fig. 3) , so satisfied the demand for an in vitro method "that accurately mimics in vivo behavior" (4). A FIGURE 4 Correlation between GGE values determined in vitro with allowance for glucose disposal, and GGE values calculated from clinically determined GI values for the same foods, as GL with adjustment for dose-dependent glucose clearance (AGL). previous study with 5 foods each fed at 3 intakes showed that the in vitro curves replicated the effect of changing food intake on blood glucose response curves (20) . The almost-perfect overall correspondence between the AGL values from clinical measurements and the in vitro netGGE data, as revealed by the Bland-Altman plot (Fig. 5) , confirms the validity of the in vitro method, although the ability to obtain a very high correlation between the in vivo and in vitro data sets was limited by the typically large variability in the clinical data.
Despite the apparent number of steps in calculating the results (methods), the method was practical and quick, because once GGE release at the different times of digestion had been calculated, the values and serving size needed only to be pasted into the calculator spreadsheet (Table 1 ) to obtain an iAUC for comparison with the reference.
The procedure used can no doubt be improved through further research aimed at refining such features as temporal changes in apparent glucose clearance (at present represented by a straight line of cumulative GGE removal), allowing for modulation of glucose clearance by some food components, and, importantly, in accurately mimicking mastication of foods, such as pulses, which do not readily disintegrate. Nonetheless, it has now been tested in 3 experiments and has been very consistent in performance; in 2 of these experiments, clinical GGE values were determined directly using a glucose standard curve (12, 20) , and, in the present study, GGE in vivo was GGE values may be used in the same way as food values, because they express the potential relative effect of a food in weight units (equivalent weight of reference) and they can be measured in vitro with the same precision as nutrients (in the present study, a CV of 6% for in vitro in contrast to a CV of 44% for clinical measurements). In food table format, their presentation would be consistent with that of other foods ( Table 3 ) and they could also be placed in nutrient information panels so the panels could indicate not only what a food is, but also what it could do, relatively (e.g. Table 4 ). Expressing the results on the basis of customarily consumed portions of entire foods is a much more helpful and meaningful guide for food data users than a value that is expressed on a carbohydrate-only basis, such as GI. People choose and consume foods, not the carbohydrates in them, and cannot easily gauge the relative glycemic impact (RGI) of foods that differ in serving size, carbohydrate content, and GI as foods do in reality. GGE values therefore allow food selection to cross the boundaries between equi-carbohydrate food groupings.
RGI connects glycemic impact to normally consumed portions and to changes in food intakes, neither of which are represented by GI values. If a comparison of the glycemic potency of equal weights of food is required, it may be obtained by expressing the RGI value on a per-100-g food basis, as are other nutrients in a nutrient information panel. And if a comparison of the glycemic potency of equal weights of carbohydrate in food, which was the purpose of GI, is desired, the foods need only be placed into equi-carbohydrate categories, as they should be to apply GI (21) , before comparing the RGI values for the amounts of food involved. Therefore, as well as being useful because it functions in the same way as a nutrient value, RGI may also be used to achieve exactly what GI was intended for, an indirect comparison of food carbohydrates in terms of glycemic potency.
Because it is a GGE loading by a food quantity, RGI need not be restricted by food regulations, because GGE is a food property measured by a modified available carbohydrate determination that is governed by well-established parameters ( Table  5) . It is well-established that relative rates of digestion are major determinants of glycemic effects that can be measured with good precision in vitro, the intrinsic glycemic potency (GI) of major sugars has been replicated in numerous studies (17) and the glucose dose-glycemic response relationship is very consistent when expressed on a glucose equivalence basis (18) . Now dose- (12) , and in so far as they are reflected in the glucose dose-glycemic response relationship, they are also likely to be consistent, intrinsic human responses to blood glucose loading. The average effect of mastication is also easy to include. GGE values are not intended to directly predict the effect of a food on any individual and they do not imply anything with respect to eventual health outcomes. Although glycemic responsiveness may vary constantly within and between individuals as a result of physiological fluctuations, the relationships between foods expressed in RGI (their GGE content) remain constant. Adding fat or certain acids to some foods may reduce the glycemic response to them more than an in vitro RGI value would predict (22, 23 ). An in vitro RGI value will, nonetheless, be a more accurate predictor of the glycemic effect than an available carbohydrate value, even when not including additional effects of fat or acid, and any overestimation of RGI would lead safely to food choices of relatively low glycemic impact. On the other hand, if the acid or fat effect is apparent with different foods, because the RGI values are relative, they remain valid indicators of relative response, even though the actual response is reduced.
It has been argued that the numerous physiological variables that affect glycemic response in vivo render in vitro analysis irrelevant (24) , because the in vivo effects cannot be represented in vitro. We have taken the opposite viewpoint in saying that it is because of the numerous uncontrolled variations that lead to clinical imprecision that an in vitro method that avoids such influences is required to act as a general guide to food choices. The present study has shown that by using a modified available carbohydrate determination that allows for factors such as food structure, relative glycemic potency of the sugars involved, and dose-dependent glucose disposal (Fig. 6) , precise and accurate in vitro RGI values may be easily obtained to guide food choices for glycemic control, not only by consumers, but also by the food industry as it attempts to develop and market foods of reduced glycemic impact.
GGE has been criticized as a complicated term for consumers. It has been used here in a scientific context because it is scientifically accurate terminology. However, in food labeling, if the context is clearly glycemic impact, glucose equivalents can be used as the unit and glycemic impact as the consumer term, as illustrated in Table 4 .
There will always be a trade-off between the precision of in vitro values and the accuracy of in vivo values, but whether accurate but very imprecise GI or GI-derived values (such as GL) perform any better than highly precise but less valid in vitro values as general guides to food choice for public health has yet to be demonstrated.
In conclusion, the RGI of customarily consumed food portions may be readily determined using in vitro digestion and a calculator spreadsheet that allows for the rate of blood glucose clearance and its dependence on portion size. When the results are expressed as GGE values, they may be used in conjunction with food composition values, as virtual food components, so that a food composition label is able to show not only what a food is, but also what it does relatively. Because they refer to whole foods and reflect the effect of food quantities, RGI (GGE intake) values should be practical for consumers and nutritionists to use, especially if expressed as glucose equivalents. And because they can express the relative glycemic impact of reference amounts customarily consumed per eating occasion, they are consistent with the food labeling preferences of the FDA.
